Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Esmeralda van der Helm
Observed name:
Esmeralda Van Der Helm
Institution:
Janssen (Netherlands)
Observed institutions:
National University of Singapore,
Duke-NUS Medical School,
Janssen (Netherlands),
Johnson & Johnson (Netherlands)
OpenAlex ID:
A5021995620
High‐Level Expression of Recombinant IgG in the Human Cell Line PER.C6
2003
·
David Jones
, Nathalie Kroos
, et al.
·
Biotechnology Progress
·
176
Novel Replication-Incompetent Vector Derived from Adenovirus Type 11 (Ad11) for Vaccination and Gene Therapy: Low Seroprevalence and Non-Cross-Reactivity with Ad5
2004
·
Lennart Holterman
, Ronald Vogels
, et al.
·
Journal of Virology
·
161
Ad35 and Ad26 Vaccine Vectors Induce Potent and Cross-Reactive Antibody and T-Cell Responses to Multiple Filovirus Species
2012
·
Roland Zahn
, Gert Gillisen
, et al.
·
PLoS ONE
·
63
PDF
Antigen capsid-display on human adenovirus 35 via pIX fusion is a potent vaccine platform
2017
·
Nadine C. Salisch
, Marija Vujadinovic
, et al.
·
PLoS ONE
·
16
PDF
Adenoviral Type 35 and 26 Vectors with a Bidirectional Expression Cassette in the E1 Region Show an Improved Genetic Stability Profile and Potent Transgene-Specific Immune Response
2017
·
Marija Vujadinovic
, Kerstin Wunderlich
, et al.
·
Human Gene Therapy
·
4
An alternative to the adenovirus inverted terminal repeat sequence increases the viral genome replication rate and provides a selective advantage in vitro
2014
·
Kerstin Wunderlich
, Esmeralda van der Helm
, et al.
·
Journal of General Virology
·
4
Show more works
View as search
Works count:
7
Citation count:
424
H-index:
4
I10-index:
4
Year
Topic
Type